Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
43.67 USD | -0.84% | -1.22% | -14.89% |
Sales 2024 * | 46.02B 3,689B | Sales 2025 * | 46.16B 3,700B | Capitalization | 88.52B 7,096B |
---|---|---|---|---|---|
Net income 2024 * | -5.4B -433B | Net income 2025 * | 10.22B 820B | EV / Sales 2024 * | 2.78 x |
Net Debt 2024 * | 39.2B 3,142B | Net Debt 2025 * | 31.85B 2,553B | EV / Sales 2025 * | 2.61 x |
P/E ratio 2024 * |
-16.6
x | P/E ratio 2025 * |
8.25
x | Employees | 34,100 |
Yield 2024 * |
5.51% | Yield 2025 * |
5.79% | Free-Float | 69.28% |
Latest transcript on Bristol-Myers Squibb Company
1 day | -0.84% | ||
1 week | -1.22% | ||
Current month | -0.61% | ||
1 month | -14.54% | ||
3 months | -10.35% | ||
6 months | -16.69% | ||
Current year | -14.89% |
Managers | Title | Age | Since |
---|---|---|---|
Chief Executive Officer | 53 | 31/01/15 | |
David Elkins
DFI | Director of Finance/CFO | 55 | 19/11/19 |
Greg Meyers
CTO | Chief Tech/Sci/R&D Officer | - | - |
Members of the board | Title | Age | Since |
---|---|---|---|
Phyllis Yale
BRD | Director/Board Member | 66 | 19/11/19 |
Peter Arduini
BRD | Director/Board Member | 59 | 31/03/16 |
Derica Rice
BRD | Director/Board Member | 59 | 31/08/20 |
Name | Weight | AuM | 1st Jan change | Investor Rating |
---|---|---|---|---|
12.97% | 0 M€ | +12.09% | - | |
4.99% | 2 M€ | -.--% | ||
4.01% | 0 M€ | +5.54% | - |
Date | Price | Change | Volume |
---|---|---|---|
08/05/24 | 43.67 | -0.84% | 11,928,339 |
07/05/24 | 44.04 | +0.32% | 11,026,912 |
06/05/24 | 43.9 | -0.20% | 9,127,651 |
03/05/24 | 43.99 | +0.66% | 12,104,489 |
02/05/24 | 43.7 | -1.15% | 15,962,587 |
Delayed Quote Nyse, May 08, 2024 at 09:00 pm
More quotesEPS Revisions
1st Jan change | Capi. | |
---|---|---|
-14.89% | 88.52B | |
+32.95% | 698B | |
+26.51% | 568B | |
-4.97% | 358B | |
+18.83% | 328B | |
+3.54% | 283B | |
+15.74% | 238B | |
+6.68% | 203B | |
-9.08% | 198B | |
+6.70% | 165B |
- Stock Market
- Equities
- BMY Stock